1-2 of 2
Fallon France
Close
Sort by
Journal Articles

Veliparib (ABT-888), Bendamustine, and Rituximab (VBR) Is Well Tolerated and Efficacious in Patients with Lymphoma: Final Analysis of a Phase 1b Clinical Trial of VB and a Cohort Expansion of Vbr in Patients with B-Cell Lymphoma

Jacob D Soumerai, MD, Andrew D Zelenetz, MD PhD, Craig H Moskowitz, MD, Anas Younes, MD, Maria Lia Palomba, MD, Paul A Hamlin, Jr., MD, Ariela Noy, MD, Steven M Horwitz, MD, Matthew J. Matasar, MD MS, Alison J Moskowitz, MD, Carol S Portlock, MD, David J Straus, MD, Alice Chen, MD, Richard F Little, MDMPH, Fallon France, Juho Whang, Nishant Mishra, Christine Jarjies, John F Gerecitano, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2691.
https://doi.org/10.1182/blood.V126.23.2691.2691
Published: 2015
Journal Articles

ABT-888 Plus Bendamustine Is Safe and Has Shown Preliminary Efficacy In Patients With Lymphoma

John F. Gerecitano, MD, PhD, Gary K Schwartz, Richard Carvajal, MD, Matthew Fury, MD, PhD, Jason Konner, David M. Hyman, MD, Mrinal Gounder, Devika Gajria, Jerrold Teitcher, Zhigang Zhang, PhD, Craig H. Moskowitz, MD, Jan H Beumer, PharmD, PhD, Alice Chen, MD, Richard F Little, MPH, MD, Fallon France, Juho Whang, Jennifer Winkelman, Megan Stasi, Corey Russell, Naomi Cazeau, Katherine Kargus, Andrew D. Zelenetz, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4366.
https://doi.org/10.1182/blood.V122.21.4366.4366
Published: 2013